UCB SA

UCB SA is a leading global biopharmaceutical company that specializes in the discovery and development of innovative medicines and solutions for individuals suffering from severe immune system and central nervous system diseases. With a steadfast commitment to science and research, UCB SA boasts a diverse portfolio of products that includes treatments for Parkinson's disease, epilepsy, rheumatoid arthritis, Crohn's disease, and more. Operating in over 40 countries and employing over 8,500 individuals worldwide, UCB SA is dedicated to enhancing the quality of life for patients and their loved ones by providing safe and effective therapies that address unmet medical needs.